Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

Title
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Authors
Keywords
-
Journal
LANCET
Volume 396, Issue 10267, Pages 1979-1993
Publisher
Elsevier BV
Online
2020-11-19
DOI
10.1016/s0140-6736(20)32466-1

Ask authors/readers for more resources

Reprint

Contact the author